Cargando…
Research on Alzheimer's syndromes is critical to improve diagnosis, patient management and non-pharmacological treatments, but is under-pursued
Autor principal: | Abbate, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618725/ https://www.ncbi.nlm.nih.gov/pubmed/36325192 http://dx.doi.org/10.3389/fnagi.2022.1039899 |
Ejemplares similares
-
Crystal Ball Health Policies: A Case Against Preventive Testing For Alzheimer’s Disease
por: Inglese, Silvia, et al.
Publicado: (2022) -
A Network Pharmacology Based Research on the Mechanism of Donepezil in Treating Alzheimer's Disease
por: Liu, Lihua, et al.
Publicado: (2022) -
Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease
por: Ye, Xian-wen, et al.
Publicado: (2022) -
Editorial: Non-coding RNA in Alzheimer's pathology and diagnosis
por: Kalra, Rajkumar Singh, et al.
Publicado: (2022) -
Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer’s disease
por: Ma, Xiaoying, et al.
Publicado: (2022)